IDIX Insider Trading Activity and SEC Form 4 Filings
IDIX insider trading summary
No open-market insider purchases or sales of Idenix Pharmaceuticals Inc (IDIX) have been reported on SEC Form 4 in the past 12 months.
Latest IDIX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 31, 2014 | Seth A Klarman | 10% Owner | Buy | $106.7M (16,420,241 @ $6.50) |
| Jan 31, 2014 | Sak Corp | 10% Owner | Buy | $106.7M (16,420,241 @ $6.50) |
| Jan 31, 2014 | Baupost Group LLC/Ma | 10% Owner | Buy | $106.7M (16,420,241 @ $6.50) |
| Mar 16, 2012 | Paul Fanning | SVP, Human Resources | Sell | $331K (30,000 @ $11.04) |
| Feb 23, 2012 | Pharma AG Novartis | 10% Owner | Buy | $6K (2,493 @ $2.56) |
| Feb 23, 2012 | AG Novartis | Insider | Buy | $3K (997 @ $2.69) |
| Feb 23, 2012 | AG Novartis | Insider | Buy | $904 (366 @ $2.47) |
| Feb 23, 2012 | Pharma AG Novartis | 10% Owner | Buy | $4K (1,321 @ $2.85) |
| Feb 23, 2012 | AG Novartis | Insider | Buy | $6K (2,493 @ $2.56) |
| Feb 23, 2012 | AG Novartis | Insider | Buy | $3K (997 @ $2.78) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.